As in the US, unproven stem cell therapies have been marketed in Australia. Last week, the Therapeutic Goods Administration (TGA, similar to US FDA) of the Australian Government tightened regulations around advertising autologous (self) human cell and tissue products. As of July 1, 2018, these products cannot be marketed to consumers, and adverse events must be reported to the TGA.
The SCI is hard at work educating the next generation and developing collaborations to move science forward.
The SCI Leadership Team continues to craft paths that enable UMN stem cell research outcomes to change the practice of medicine. Three budding efforts are highlighted in this issue.
- Chan SSK, Arpke RW, Filareto A, Xie N, Pappas MP, Penaloza JS, Perlingeiro RCR, Kyba M. Skeletal Muscle Stem Cells from PSC-Derived Teratomas Have Functional Regenerative Capacity. Cell Stem Cell. 2018; 23, 74-85.